keuhkofibroosille

Keuhkofibroosille, also known as pulmonary fibrosis, is a progressive and irreversible lung disease characterized by the scarring of lung tissue. This scarring leads to a decline in lung function and can eventually result in respiratory failure. The condition is typically caused by exposure to irritants, such as asbestos, silica, or certain chemicals, or by autoimmune disorders. Other risk factors include radiation therapy, certain medications, and genetic predispositions.

The primary symptom of pulmonary fibrosis is shortness of breath, which can worsen over time. Other symptoms may include coughing, fatigue, and chest pain. The diagnosis of pulmonary fibrosis often relies on imaging tests, such as high-resolution computed tomography (HRCT), and lung function tests. There is no cure for pulmonary fibrosis, but treatment focuses on managing symptoms and slowing the progression of the disease.

Management strategies include medications to reduce inflammation and improve lung function, as well as oxygen therapy to support breathing. In some cases, lung transplantation may be considered for patients with severe disease. Lifestyle modifications, such as avoiding known irritants and maintaining a healthy diet, can also help manage the condition. Supportive care, including physical therapy and pulmonary rehabilitation, can improve quality of life and help patients cope with the challenges of living with pulmonary fibrosis.